sulfasalazine has been researched along with Right Ventricular Dysfunction in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"Of 51 MCTD patients, 20 had pulmonary arterial hypertension (PAH) in the past 2 years." | 1.34 | Diastolic function of the heart in mixed connective tissue disease. ( Bodolay, E; Hegedus, I; Szegedi, G; Végh, J; Zeher, M, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Végh, J | 1 |
Hegedus, I | 1 |
Szegedi, G | 1 |
Zeher, M | 1 |
Bodolay, E | 1 |
1 other study available for sulfasalazine and Right Ventricular Dysfunction
Article | Year |
---|---|
Diastolic function of the heart in mixed connective tissue disease.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclophosphamide; Diastole; Drug Therapy, Comb | 2007 |